The UroLift™ System Procedure and Device

The #1 minimally invasive BPH procedure chosen by urologists in the U.S.1

Contact a Urology Consultant

About the Procedure

The UroLift™ System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH), including lateral and median lobe hyperplasia, in men 45 years of age or older.

Enlarged Prostate

An enlarged prostate presses on and blocks the urethra, causing bothersome urinary symptoms.

Step 1

The UroLift™ Delivery Device is inserted transurethrally through a rigid sheath under cystoscopic visualization in order to reach the targeted area of obstruction.

Step 2

The obstructing prostatic lobes are retracted by small, permanent UroLift™ Implants which are deployed via a needle that comes out of the delivery device.

Step 3

The UroLift™ System treatment provides fast and reliable symptom relief by opening the obstructed urethra.

A BPH Solution You Can Be Confident In

  • Can be performed in office-based and outpatient settings with local anesthesia; minimal downtime for patients2

  • Preserves†3 and possibly improves†4 sexual function 

  • Minimal downtime2 and lowest catheterization rate of leading BPH procedures2,3,5-8
  • Effective alternative to drug therapy without heating, cutting or removing prostate tissue3
  • The largest healthcare utilization study for BPH therapies in the U.S. shows the UroLift™ System has the lowest complication rate9

UroLift™ Delivery Devices and Implants

Contact a Urology Consultant

Now it’s easier to treat a broader spectrum of BPH patients, including lateral and median lobe hyperplasia, with the full line of UroLift™ products.

Contact a Urology Consultant

UroLift™ 2 System

Inserted transuretherally through a rigid sheath under cystoscopic visualization to reach the targeted area of obstruction. Typically one Delivery Handle is used per procedure, and individual Implant Cartridges deliver each UroLift™ Implant.

UroLift ATC™ System

Delivers the same, proven implant through an enhanced delivery device tip that enables urologists to more easily treat BPH patients with challenging anatomies, including an obstructive median lobe and large lateral lobes.

UroLift™ Implant

The obstructing prostatic lobes are held apart by small UroLift Implants that are deployed by the delivery device. Each implant is made with common implantable materials: nitinol, stainless steel, and PET suture. Typically, four to six implants are placed into the prostate.

MRI Information

The UroLift™ Implant is MR conditional, and patients can be safely scanned, provided the following conditions are met:

  • Static magnetic field of 3.0 Tesla or less 
  • Maximum spatial field gradient of 1,500 Gauss/cm (15 T/m) (extrapolated) 
  • Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 4 W/kg for 15 minutes of continuous scanning

Under the scan conditions defined above, the UroLift™ Implant is expected to produce a maximum temperature rise of 2.4°C after 15 minutes of continuous scanning (i.e., per pulse sequence).